Source - RNS
RNS Number : 7442J
The MedicX Fund Limited
13 September 2016



For immediate release

13 September 2016


MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")


Scrip Dividend Declaration



MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), elections were received in respect of 2.7 per cent. of the ordinary shares in issue as at the record date of 19 August 2016. Electing shareholders will receive ordinary shares of no par value in the Company ("Shares") in lieu of receiving cash for the September 2016 dividend in respect of the quarter ended 30 June 2016.  Accordingly, 169,084 Shares will be sold out of treasury by the Company on 30 September 2016 to shareholders who elected to participate in the Scrip Dividend Alternative.


The Shares will rank pari passu with the existing ordinary shares.


Following the transaction, the Company is expected to have 394,252,182 ordinary shares in issue, of which 8,185,338 will be held in treasury. Accordingly the total voting rights in issue will be 386,066,844.


Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (




For further information please contact:


MedicX Fund                                                                  +44 (0) 1481 723 450

David Staples, Chairman


Octopus Healthcare Group                                               +44 (0) 20 3142 4820

Mike Adams, Chief Executive Officer


Buchanan                                                                        +44 (0) 20 7466 5000

Charles Ryland/Vicky Watkins


Information on MedicX Fund Limited


MedicX Fund Limited ("MXF", "the Fund" or "the Company", or together with its subsidiaries, "the Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 152 properties.


The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1 billion of healthcare investments across a number of platforms, with a focus on four core areas: GP surgeries, care homes, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £5.5 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.comNeither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 


This information is provided by RNS
The company news service from the London Stock Exchange